參考文獻/References:
[1] RITTER J,BIELACK S S.Osteosarcoma[J].Ann Oncol,2010,21(7):320-325.
[2] GILL J,GORLICK R.Advancing therapy for osteosarco-ma[J].Nat Rev Clin Oncol,2021,18(10):609-624.
[3] TASSONE P,DI MARTINO M T,ARBITRIO M,et al.Safety and activity of the first-in-class locked nucleic acid(LNA)miR-221 selective inhibitor in refractory advanced cancer patients:a first-in-human,phase 1,open-label,dose-escalation study[J].J Hematol Oncol,2023,16(1):68.
[4] WANG C,ZHANG Y,KONG W,et al.Delivery of miRNAs using nanoparticles for the treatment of osteosarcoma[J].Int J Nanomedicine,2024,19:8641-8660.
[5] KIM T,CROCE C M.MicroRNA:trends in clinical trials of cancer diagnosis and therapy strategies[J].Exp Mol Med,2023,55(7):1314-1321.
[6] SALAH Z,ARAFEH R,MAXIMOV V,et al.miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells[J].Oncotarget,2015,6(7):4920-4935.
[7] 李帥.MicroRNA-27a調(diào)控骨肉瘤生物學行為的機制研究[D].武漢:華中科技大學,2015.
[8] 孫琛,梁廷明.miR-27在腫瘤、心血管疾病和能量代謝中的作用研究進展[J].生命科學,2016,28(1):93-99.
[9] TANG J,ZHAO H,CAI H,et al.Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma[J].Biomed Pharmacother,2015,71:222-226.
[10] SHI J,YANG C,AN J,et al.KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway[J].J Exp Clin Cancer Res,2021,40(1):148.
[11] DURAN-SANCHON S,MORENO L,G?MEZ-MATAS J,et al.Fecal microrna-based algorithm increases effectiveness of fecal immunochemical test-based screening for colorectal cancer[J].Clin Gastroenterol Hepatol,2021,19(2):323-330.
[12] DUWE L,MUNOZ-GARRIDO P,LEWINSKA M,et al.MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells[J].J Hepatol,2023,78(2):364-375.
[13] XI Y,SHEN Y,WU D,et al.CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p[J].Mol Cancer,2022,21(1):145.
[14] ZHU L,WANG Z,FAN Q,et al.microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS[J].Oncol Rep,2014,31(1):280-286.
[15] EICHELMANN A K,MAYNE G C,CHIAM K,et al.Mutant p53 mediates sensitivity to cancer treatment agents in oesophageal adenocarcinoma associated with microrna and slc7a11 expression[J].Int J Mol Sci,2021,22(11):5547.
[16] MAGHSUDLU M,FARASHAHI YAZD E,AMIRIANI T.Increased expression of miR-27a and miR-24-2 in esophageal squamous cell carcinoma[J].J Gastrointest Cancer,2020,51(1):227-233.
[17] JI Z,SHEN J,LAN Y,et al.Targeting signaling pathways in osteosarcoma:mechanisms and clinical studies[J].MedComm(2020),2023,4(4):e308.
[18] CHEN L,GONG X,HUANG M.Marsdenia tenacissima extract prevents the malignant progression of glioma through upregulating lncRNA MEG3 and SFRP1-dependent inhibition of Wnt/β-catenin pathway[J].CNS Neurosci Ther,2023,29(5):1272-1289.
[19] MU Y,ZHANG L,CHEN X,et al.Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway[J].Biosci Rep,2019,39(6):BSR20182366.
[20] LI S,WU X,PEI Y,et al.PTHR1 may be involved in progression of osteosarcoma by regulating miR-124-3p-AR-Tgfb1i1,miR-27a-3p-PPARG-Abca1,andmiR-103/590-3p-AXIN2 axes[J].DNA Cell Biol,2019,38(11):1323-1337.
[21] XU X,ZHANG M,XU F,et al.Wnt signaling in breast can-cer:biological mechanisms,challenges and opportunities[J].Mol Cancer,2020,19(1):165.
[22] FALCICCHIA C,TOZZI F,ARANCIO O,et al.Involvement of p38 MAPK in synaptic function and dysfunction[J].Int J Mol Sci,2020,21(16):5624.
[23] JANSEN R A,MAINARDI S,DIAS M H,et al.Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in KRAS-mutant cancers[J].Proc Natl Acad Sci USA,2024,121(9):e2319492121.
[24] WAN X,HUANG W,YANG S,et al.Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression[J].Int J Biochem Cell Biol,2016,79:249-260.
[25] PAN W,WANG H,JIANWEI R,et al.MicroRNA-27a promotes proliferation,migration and invasion by targeting MAP2K4 in human osteosarcoma cells[J].Cell Physiol Biochem,2014,33(2):402-412.
[26] DERYNCK R,TURLEY S J,AKHURST R J.TGFβ biology in cancer progression and immunotherapy[J].Nat Rev Clin Oncol,2021,18(1):9-34.
[27] ZHANG T,WANG X F,WANG Z C,et al.Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar for-mation[J].Biomed Pharmacother,2020,129:110287.
[28] CHAE D K,BAN E,YOO Y S,et al.MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer[J].Mol Carcinog,2017,56(8):1992-1998.
[29] XU Q,TONG J L,ZHANG C P,et al.miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4[J].PLoS One,2017,12(10):e0186718.
[30] RU L,WANG X M,NIU J Q.The miR-23-27-24 cluster:an emerging target in NAFLD pathogenesis[J].Acta Pharmacol Sin,2022,43(5):1167-1179.
[31] 馬青源,蒲沛東,韓飛,等.miR-27b-3p調(diào)控SMAD1對骨肉瘤細胞增殖、遷移和侵襲作用的影響[J].山東大學學報(醫(yī)學版),2020,58(7):32-37.
[32] LIN T,MA Q,ZHANG Y,et al.MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1[J].Oncol Lett,2018,15(1):1067-1071.
[33] ZHANG S,CHEN R.LINC00891 attenuates the proliferation and metastasis of osteosarcoma cells via miR-27a-3p/TET1 axis[J].Genet Test Mol Biomarkers,2023,27(8):248-257.
[34] LIU J,LI M,LIU X,et al.miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1[J].Int J Oncol,2018,52(4):1295-1304.
[35] FAUBERT B,SOLMONSON A,DEBERARDINIS R J.Metabolic reprogramming and cancer progression[J].Science,2020,368(6487):eaaw5473.
[36] XIA L,OYANG L,LIN J,et al.The cancer metabolic reprogramming and immune response[J].Mol Cancer,2021,20(1):28.
[37] BARISCIANO G,COLANGELO T,ROSATO V,et al.miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer[J].Br J Cancer,2020,122(9):1354-1366.
相似文獻/References:
[1]于雅麗,王雷鳴.二氯乙酸鈉對人骨肉瘤MG63細胞增殖、凋亡和遷移的影響[J].中醫(yī)正骨,2017,29(01):11.
YU Yali,WANG Leiming.Effect of sodium dichloroacetate on cell proliferation,apoptosis and migration in human MG63 osteosarcoma cells[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(03):11.
[2]羅明星,劉丙根,羅文禮,等.保肢與截肢治療后骨肉瘤患者肢體功能及生活質(zhì)量的Meta分析[J].中醫(yī)正骨,2017,29(07):41.
LUO Mingxing,LIU Binggen,LUO Wenli,et al.Comparison of limb salvage and amputation on limb function and life quality of patients with osteosarcoma:a meta analysis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(03):41.
[3]梁文娜,李西海,李燦東.血清microRNA與絕經(jīng)后骨質(zhì)疏松癥腎虛證的關系[J].中醫(yī)正骨,2017,29(10):53.
[4]丁聚賢,謝興文,許偉,等.中醫(yī)藥在骨肉瘤放化療中的作用研究進展[J].中醫(yī)正骨,2018,30(05):43.
[5]孫曉輝,趙斌,劉洋,等.負載microRNA-27b-骨髓間充質(zhì)干細胞來源外泌體的軟骨細胞-聚乳酸羥基乙酸共聚物骨軟骨復合體移植治療軟骨缺損的實驗研究[J].中醫(yī)正骨,2021,33(01):1.
SUN Xiaohui,ZHAO Bin,LIU Yang,et al.MicroRNA-27b-bone marrow mesenchymal stem cell derived exosomes-laden chondrocytes-poly(lactic-co-glycolic acid)osteochondral complex transplantation for treatment of osteochondral defects:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(03):1.
[6]羅漫麗,黃滿玉,李東升,等.多種血清腫瘤相關抗原自身抗體聯(lián)合檢測對骨肉瘤的診斷價值研究[J].中醫(yī)正骨,2021,33(04):32.
LUO Manli,HUANG Manyu,LI Dongsheng,et al.A study of the clinical value of combined detection on serum autoantibodies against tumor-associated antigens in the diagnosis of osteosarcomas[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(03):32.
[7]王最,徐佳妮,吳良邦,等.骨關節(jié)炎軟骨損傷中miRNA-214的作用機制及靶向基因研究[J].中醫(yī)正骨,2023,35(03):6.
WANG Zui,XU Jiani,WU Liangbang,et al.Mechanism and targeted genes of miRNA-214 in osteoarthritis-induced cartilage injury[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(03):6.
[8]馬力,汪盛玉,韓軍燁,等.長鏈非編碼RNA HAGLR與微RNA-19a-3p對股骨頸骨折內(nèi)固定術(shù)后骨折不愈合的影響[J].中醫(yī)正骨,2023,35(04):1.
MA Li,WANG Shengyu,HAN Junye,et al.Effects of long non-coding RNA HAGLR and microRNA-19a-3p on bone nonunion after internal fixation of femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(03):1.
[9]翟晨駿,劉磊,周鳴,等.圍手術(shù)期外周靜脈血中長鏈非編碼RNA PAX8-AS1與微RNA-1252-5p表達水平對脛骨骨折內(nèi)固定術(shù)后骨折愈合的影響[J].中醫(yī)正骨,2023,35(08):8.
ZHAI Chenjun,LIU Lei,ZHOU Ming,et al.Effects of expression levels of long non-coding RNA PAX8-AS1 and microRNA-1252-5p in perioperative peripheral venous blood on fracture healing after internal fixation for treatment of tibial fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(03):8.